M&T Bank’s Pfizer PFE Stock Holding History

M&T Bank’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.89K	Buy	698 +251	+56%	+$6.68K	﹤0.01%	1702
2025 Q4	$3.58K	Sell	447 -22	-5%	-$555	﹤0.01%	1690
2025 Q3	$24.4K	Buy	469 +6	+1%	+$148	﹤0.01%	1454
2025 Q2	$8.33K	Buy	463 +77	+20%	+$1.8K	﹤0.01%	1542
2025 Q1	$11.2K	Buy	386 +30	+8%	+$785	﹤0.01%	1519
2024 Q4	$12.8K	Sell	356 -24	-6%	-$651	﹤0.01%	1603
2024 Q3	$13.3K	Sell	380 -9	-2%	-$263	﹤0.01%	1618
2024 Q2	$11.7K	Buy	389 +56	+17%	+$1.54K	﹤0.01%	1566
2024 Q1	$1.33K	Buy	333 +110	+49%	+$3.05K	﹤0.01%	1606
2023 Q4	$669	Sell	223 -33	-13%	-$998	﹤0.01%	1621
2023 Q3	$1.02K	Buy	256 +2	+0.8%	+$71	﹤0.01%	1580
2023 Q2	$3.05K	Sell	254 -20	-7%	-$778	﹤0.01%	1615
2023 Q1	$2.95K	Buy	+274	New	+$11.8K	﹤0.01%	1646
2022 Q4	–	Sell	-524	Closed	-$39K	–	1681
2022 Q3	$39K	Buy	524 +125	+31%	+$6.07K	﹤0.01%	1544
2022 Q2	$67K	Sell	399 -16	-4%	-$815	﹤0.01%	1495
2022 Q1	$82K	Buy	415 +38	+10%	+$1.97K	﹤0.01%	1438
2021 Q4	$151K	Sell	377 -149	-28%	-$7.38K	﹤0.01%	1478
2021 Q3	$23K	Buy	526 +2	+0.4%	+$89	﹤0.01%	1525
2021 Q2	$22K	Buy	524 +362	+223%	+$14.1K	﹤0.01%	1549
2021 Q1	$17K	Buy	162 +12	+8%	+$426	﹤0.01%	1508
2020 Q4	$3K	Buy	150 +76	+103%	+$2.79K	﹤0.01%	1670
2020 Q3	$3K	Buy	74 +17	+30%	+$596	﹤0.01%	1573
2020 Q2	$2K	Hold	57	–	–	﹤0.01%	1576
2020 Q1	$1K	Buy	57 +3	+6%	+$102	﹤0.01%	1546
2019 Q4	$2K	Buy	+54	New	+$1.92K	﹤0.01%	1401
2019 Q3	–	Sell	-57	Closed	-$5K	–	1649
2019 Q2	$5K	Buy	57 +5	+10%	+$199	﹤0.01%	1566
2019 Q1	$4K	Hold	52	–	–	﹤0.01%	1554
2018 Q4	$11K	Sell	52 -5	-9%	-$208	﹤0.01%	1399
2018 Q3	$13K	Buy	57 +5	+10%	+$192	﹤0.01%	1505
2018 Q2	$1K	Hold	52	–	–	﹤0.01%	1548
2018 Q1	$1K	Hold	52	–	–	﹤0.01%	1564
2017 Q4	$1K	Hold	52	–	–	﹤0.01%	1623
2017 Q3	$1K	Buy	+52	New	+$1.67K	﹤0.01%	1616
2017 Q2	–	Sell	-52	Closed	-$1K	–	1674
2017 Q1	$1K	Buy	+52	New	+$1.64K	﹤0.01%	1653
2016 Q3	–	Sell	-53	Closed	-$2K	–	1763
2016 Q2	$2K	Buy	+53	New	+$1.69K	﹤0.01%	1656
2016 Q1	–	Sell	-5,270	Closed	-$1K	–	1786
2015 Q4	$1K	Buy	+5,270	New	+$166K	﹤0.01%	1735
2015 Q3	–	Sell	-5,692	Closed	-$1K	–	1956
2015 Q2	$1K	Sell	5,692 -6,956	-55%	-$227K	﹤0.01%	2079
2015 Q1	$17K	Sell	12,648 -8,854	-41%	-$281K	﹤0.01%	1979
2014 Q4	$11K	Buy	21,502 +10,962	+104%	+$314K	﹤0.01%	2036
2014 Q3	$3K	Buy	+10,540	New	+$296K	﹤0.01%	2238

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

M&T Bank's PFE Position: Q1 2026 in Review

M&T Bank increased its Pfizer (PFE) stake by 4.8% in Q1 2026, buying an estimated $3.22M and bringing the position to 2,660,449 shares worth $74.7M. The position accounts for 0.26% of the portfolio, ranked #86.

M&T Bank first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $172M in Q3 2018. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

M&T Bank held 2,660,449 shares of Pfizer worth $74.7M as of Q1 2026.
M&T Bank bought 120,908 Pfizer shares in Q1 2026, an estimated $3.22M.
Pfizer made up 0.26% of M&T Bank's portfolio in Q1 2026, its #86 holding.
M&T Bank first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
M&T Bank's Pfizer position peaked at $172M in Q3 2018.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.